Dermatomyositis and polymyositis (myositis) trials in Croatia

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  Phase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)

  Where

  Grad Zagreb, Rijeka

  Age

  18 years and over

  People

  78 worldwide

  Run by

  Chugai Pharmaceutical Co. Ltd.

  See details and how to join2024-511346-39-00
• Phase 1Taking people
  Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

  Where

  Grad Zagreb, Rijeka

  Age

  18 years to 85 years

  People

  144 worldwide

  Run by

  Chugai Pharmaceutical

  See details and how to joinNCT06371417 · EU 2023-507692-21-00
• Phase 1Enrolling by invitation
  Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

  Where

  Rijeka, Zagreb

  Age

  18 years to 85 years

  People

  144 worldwide

  Run by

  Chugai Pharmaceutical

  See details and how to joinNCT06723106